ANKRD62 Modulates NF ‐ κB Signaling to Promote Proliferation and Migration in UCEC
Cancer Medicine · 2026-04 · 15 (4)
DOI: 10.1002/cam4.71822 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 15.04.2026. Verfasst von Chenjun Hao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated Hospital Group of Guangdong Medical University Panyu He Xian Memorial Hospital/Panyu Women and Children's Medical Center, Guangdong Medica…. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Carcinoma, Cell Proliferation, Cell Movement. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Guangzhou Panyu District science and technology plan major medical and health projects.
Abstract (Originalsprache)
Members of the ankyrin repeat domain (ANKRD) family are involved in multiple cellular functions, including cell cycle regulation, cell adhesion, and signaling, and have been implicated in the pathogenesis of various cancers. However, the function of ANKRD62, a recently identified member of this family, remains largely unexplored. This study investigated the clinical significance and biological function of ANKRD62 in uterine corpus endometrial carcinoma (UCEC). Through gene expression profiling, we identified ANKRD62 upregulation in UCEC tissues compared to paired adjacent normal tissues. Using overexpression and shRNA‐mediated knockdown in cell lines and mouse models, we demonstrated that ANKRD62 is significantly upregulated in UCEC tissues, with expression levels positively correlated with tumor grade and inversely associated with patient survival. In vitro functional assays revealed that ANKRD62 overexpression markedly enhanced UCEC cell proliferation and migration, whereas ANKRD62 knockdown suppressed these malignant phenotypes without significantly affecting apoptosis. Consistent with these findings, in vivo experiments showed that ANKRD62‐overexpressing cells exhibited accelerated tumor growth and increased metastatic potential. Mechanistically, ANKRD62 was found to be associated with NF‐κB pathway modulation, promoting p65 nuclear translocation and phosphorylation, thereby affecting cellular function. In summary, this study provides the first evidence that ANKRD62 acts as a critical oncogenic driver in UCEC progression and unveils its functional association with NF‐κB signaling. These findings highlight the potential of ANKRD62 as a novel therapeutic target and offer new insights into the molecular mechanisms underlying UCEC pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Affiliated Hospital Group of Guangdong Medical University Panyu He Xian Memorial Hospital/Panyu Women and Children's Medical Center, Guangdong Medical University (Guangzhou Panyu District Maternal and Child Health Hospi…
- Huadong Hospital Affiliated to Fudan University, Shanghai, China.
- Gynaecology and Obstetrics Department, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou, China.
ORCID-Profile: Yanqiu Li
Förderung
- Guangzhou Panyu District science and technology plan major medical and health projects
Zitieren
APA
Hao, C., Li, Y., Li, Z., Fu, L., & Lin, S. (2026). ANKRD62 Modulates NF ‐ κB Signaling to Promote Proliferation and Migration in UCEC. Cancer Medicine, 15(4). https://doi.org/10.1002/cam4.71822
Vancouver
Hao C, Li Y, Li Z, Fu L, Lin S. ANKRD62 Modulates NF ‐ κB Signaling to Promote Proliferation and Migration in UCEC. Cancer Medicine. 2026;15(4). doi:10.1002/cam4.71822
BibTeX
@article{Hao2026,
author = {Hao, Chenjun and Li, Yanqiu and Li, Zhi and Fu, Lisheng and Lin, Shaodan},
title = {ANKRD62 Modulates NF ‐ κB Signaling to Promote Proliferation and Migration in UCEC},
journal = {Cancer Medicine},
year = {2026},
volume = {15},
number = {4},
doi = {10.1002/cam4.71822}
}
EUVIMED